Sabin Vaccine Institute Receives $20.5 Million from BARDA with Potential of Up to $128 Million to Develop Ebola Sudan and Marburg Vaccines
WASHINGTON, Oct. 1 (Korea Bizwire) — The Sabin Vaccine Institute (Sabin) today announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Under the terms of this agreement, the full program is expected [...]